Atrial fibrillation monitoring to reduce thromboembolic risk: Selecting the patient and the monitoring device

Rev Port Cardiol. 2017 Jul-Aug;36(7-8):547-549. doi: 10.1016/j.repc.2016.12.011. Epub 2017 Jul 3.

[Article in English, Portuguese]

Authors

Sérgio Barra¹, Rui Providência²

Affiliations

¹ Cardiology Department, Papworth Hospital NHS Foundation Trust, Cambridge, UK. Electronic address: sergioncbarra@gmail.com.
² Barts Heart Centre, Barts Health NHS Trust, London, UK.

PMID: 28684124
DOI: 10.1016/j.repc.2016.12.011

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anticoagulants
Atrial Fibrillation*
Humans
Risk
Risk Factors
Thromboembolism*

Substances

Anticoagulants